Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Kramer

Showing results (61-70 of 104) with videos related to

Pageof 11
Sort By:
Journal of Imaging Informatics in Medicine|June 17, 2024
Evolutionary Strategies AI Addresses Multiple Technical Challenges in Deep Learning Deployment: Proof-of-Principle Demonstration for Neuroblastoma Brain Metastasis DetectionSubhanik Purkayastha, Hrithwik Shalu, David Gutman, et al.
Pediatric Blood & Cancer|November 2, 2007
Brain-sparing radiotherapy for neuroblastoma skull metastasesSuzanne L Wolden, Christopher A Barker, Brian H Kushner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 9, 2016
Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II StudyShakeel Modak, Pat Zanzonico, Jorge A Carrasquillo, et al.
Pediatric Radiology|December 21, 2010
Variable MR imaging appearances of focal nodular hyperplasia in pediatric cancer patientsRichard K G Do, Sara D Shaylor, Jinru Shia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2025
A Phase II Trial of Naxitamab plus Stepped-up Dosing of GM-CSF for Patients with High-Risk Neuroblastoma in First Complete RemissionBrian H Kushner, Shakeel Modak, Audrey Mauguen, et al.
Cancer|April 3, 2014
Striking dichotomy in outcome of MYCN-amplified neuroblastoma in the contemporary eraBrian H Kushner, Shakeel Modak, Kim Kramer, et al.
International Journal of Cancer|September 22, 2016
A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastomaBrian H Kushner, Nai-Kong V Cheung, Shakeel Modak, et al.
Pediatric Blood & Cancer|July 2, 2020
Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastomaLeo Y Luo, Kim Kramer, Nai-Kong V Cheung, et al.
Journal of Pediatric Surgery|March 16, 2004
The impact of gross total resection on local control and survival in high-risk neuroblastomaMichael P La Quaglia, Brian H Kushner, Wendy Su, et al.
Pediatric Blood & Cancer|March 10, 2010
Hypothyroidism after 131I-monoclonal antibody treatment of neuroblastomaSonal Bhandari, Nai-Kong V Cheung, Brian H Kushner, et al.
Pageof 11

Showing results (61-70 of 104) with videos related to

Sort By:
Pageof 11
Journal of Imaging Informatics in Medicine|June 17, 2024
Evolutionary Strategies AI Addresses Multiple Technical Challenges in Deep Learning Deployment: Proof-of-Principle Demonstration for Neuroblastoma Brain Metastasis DetectionSubhanik Purkayastha, Hrithwik Shalu, David Gutman, et al.
Pediatric Blood & Cancer|November 2, 2007
Brain-sparing radiotherapy for neuroblastoma skull metastasesSuzanne L Wolden, Christopher A Barker, Brian H Kushner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 9, 2016
Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II StudyShakeel Modak, Pat Zanzonico, Jorge A Carrasquillo, et al.
Pediatric Radiology|December 21, 2010
Variable MR imaging appearances of focal nodular hyperplasia in pediatric cancer patientsRichard K G Do, Sara D Shaylor, Jinru Shia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2025
A Phase II Trial of Naxitamab plus Stepped-up Dosing of GM-CSF for Patients with High-Risk Neuroblastoma in First Complete RemissionBrian H Kushner, Shakeel Modak, Audrey Mauguen, et al.
Cancer|April 3, 2014
Striking dichotomy in outcome of MYCN-amplified neuroblastoma in the contemporary eraBrian H Kushner, Shakeel Modak, Kim Kramer, et al.
International Journal of Cancer|September 22, 2016
A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastomaBrian H Kushner, Nai-Kong V Cheung, Shakeel Modak, et al.
Pediatric Blood & Cancer|July 2, 2020
Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastomaLeo Y Luo, Kim Kramer, Nai-Kong V Cheung, et al.
Journal of Pediatric Surgery|March 16, 2004
The impact of gross total resection on local control and survival in high-risk neuroblastomaMichael P La Quaglia, Brian H Kushner, Wendy Su, et al.
Pediatric Blood & Cancer|March 10, 2010
Hypothyroidism after 131I-monoclonal antibody treatment of neuroblastomaSonal Bhandari, Nai-Kong V Cheung, Brian H Kushner, et al.
Pageof 11